Cite
HARVARD Citation
Li, Y. et al. (2022). Disease monitoring of epidermal growth factor receptor (EGFR)‐mutated non‐small‐cell lung cancer patients treated with tyrosine kinase inhibitors via EGFR status in circulating tumor DNA. Thoracic cancer. 13 (15), pp. 2201-2209. [Online].